(NASDAQ: TWST) Twist Bioscience's forecast annual revenue growth rate of 21.43% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.56%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.4%.
Twist Bioscience's revenue in 2026 is $431,798,000.On average, 14 Wall Street analysts forecast TWST's revenue for 2027 to be $34,995,759,186, with the lowest TWST revenue forecast at $32,717,598,472, and the highest TWST revenue forecast at $36,863,813,347. On average, 14 Wall Street analysts forecast TWST's revenue for 2028 to be $40,435,628,218, with the lowest TWST revenue forecast at $35,728,808,972, and the highest TWST revenue forecast at $43,464,396,797.
In 2029, TWST is forecast to generate $49,937,684,177 in revenue, with the lowest revenue forecast at $44,525,406,411 and the highest revenue forecast at $55,354,351,462.